165 related articles for article (PubMed ID: 35643870)
61. Clinical Impact of PD-L1 Expression for Survival in Curatively Resected Colon Cancer.
Jung DH; Park HJ; Jang HH; Kim SH; Jung Y; Lee WS
Cancer Invest; 2020 Aug; 38(7):406-414. PubMed ID: 32762373
[TBL] [Abstract][Full Text] [Related]
62. Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer.
Nero C; Romito I; Spadola S; Romito A; Turco LC; Cosentino F; De Ninno M; Catena U; De Cicco Nardone A; Moroni R; Zannoni G; Fagotti A; Scambia G
Fertil Steril; 2022 Jan; 117(1):160-168. PubMed ID: 34656305
[TBL] [Abstract][Full Text] [Related]
63. Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology.
Mylvaganam G; Yanez AG; Maus M; Walker BD
Front Immunol; 2019; 10():2109. PubMed ID: 31552045
[TBL] [Abstract][Full Text] [Related]
64. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S
Haematologica; 2013 Jun; 98(6):953-63. PubMed ID: 23300177
[TBL] [Abstract][Full Text] [Related]
65. Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma.
Noh BJ; Kwak JY; Eom DW
BMC Cancer; 2020 Jan; 20(1):58. PubMed ID: 31992245
[TBL] [Abstract][Full Text] [Related]
66. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
[TBL] [Abstract][Full Text] [Related]
67. Prediction of PD-L1 inhibition effects for HIV-infected individuals.
Zheltkova V; Argilaguet J; Peligero C; Bocharov G; Meyerhans A
PLoS Comput Biol; 2019 Nov; 15(11):e1007401. PubMed ID: 31693657
[TBL] [Abstract][Full Text] [Related]
68. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
Front Immunol; 2020; 11():574491. PubMed ID: 33193363
[TBL] [Abstract][Full Text] [Related]
69. Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers.
Green AR; Aleskandarany MA; Ali R; Hodgson EG; Atabani S; De Souza K; Rakha EA; Ellis IO; Madhusudan S
Cancer Immunol Res; 2017 Apr; 5(4):292-299. PubMed ID: 28254786
[TBL] [Abstract][Full Text] [Related]
70. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
Dai C; Liang S; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
[TBL] [Abstract][Full Text] [Related]
71. Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.
Wang H; Li Z; Dong B; Sun W; Yang X; Liu R; Zhou L; Huang X; Jia L; Lin D
Diagn Pathol; 2018 May; 13(1):30. PubMed ID: 29789013
[TBL] [Abstract][Full Text] [Related]
72. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
[TBL] [Abstract][Full Text] [Related]
73. High CD8
Koemans WJ; van Dieren JM; van den Berg JG; Meijer GA; Snaebjornsson P; Chalabi M; Lecot F; Riedl R; Krijgsman O; Hofland I; Broeks A; Voncken FEM; Peppelenbosch MP; Sosef MN; van Sandick JW; Kodach LL
Histopathology; 2021 Aug; 79(2):238-251. PubMed ID: 33660299
[TBL] [Abstract][Full Text] [Related]
74. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia.
Tendeiro R; Foxall RB; Baptista AP; Pinto F; Soares RS; Cavaleiro R; Valadas E; Gomes P; Victorino RM; Sousa AE
AIDS; 2012 Jun; 26(9):1065-71. PubMed ID: 22441249
[TBL] [Abstract][Full Text] [Related]
75. Comprehensive immune characterization and T-cell receptor repertoire heterogeneity of retroperitoneal liposarcoma.
Yan L; Wang Z; Cui C; Guan X; Dong B; Zhao M; Wu J; Tian X; Hao C
Cancer Sci; 2019 Oct; 110(10):3038-3048. PubMed ID: 31385405
[TBL] [Abstract][Full Text] [Related]
76. Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy.
Kagamu H; Yamasaki S; Kitano S; Yamaguchi O; Mouri A; Shiono A; Nishihara F; Miura Y; Hashimoto K; Imai H; Kaira K; Kobayashi K; Kanai Y; Shibata T; Horimoto K
Cancer Res; 2022 Dec; 82(24):4641-4653. PubMed ID: 36219677
[TBL] [Abstract][Full Text] [Related]
77. Oral immune dysfunction is associated with the expansion of FOXP3
Bhaskaran N; Schneider E; Faddoul F; Paes da Silva A; Asaad R; Talla A; Greenspan N; Levine AD; McDonald D; Karn J; Lederman MM; Pandiyan P
Nat Commun; 2021 Aug; 12(1):5143. PubMed ID: 34446704
[TBL] [Abstract][Full Text] [Related]
78. Reduced Number and Immune Dysfunction of CD4+ T Cells in Obesity Accelerate Colorectal Cancer Progression.
Yamada K; Saito M; Ando M; Abe T; Mukoyama T; Agawa K; Watanabe A; Takamura S; Fujita M; Urakawa N; Hasegawa H; Kanaji S; Matsuda T; Oshikiri T; Kakeji Y; Yamashita K
Cells; 2022 Dec; 12(1):. PubMed ID: 36611881
[TBL] [Abstract][Full Text] [Related]
79. Inflammatory and immune checkpoint markers are associated with the severity of aortic stenosis.
Erkhem-Ochir B; Tatsuishi W; Yokobori T; Ohno T; Hatori K; Handa T; Oyama T; Shirabe K; Saeki H; Abe T
JTCVS Open; 2021 Mar; 5():1-12. PubMed ID: 36003161
[TBL] [Abstract][Full Text] [Related]
80. Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum.
Meyer-Myklestad MH; Medhus AW; Stiksrud B; Lorvik KB; Seljeflot I; Hansen SH; Holm K; Hov JR; Kvale D; Dyrhol-Riise AM; Kummen M; Trøseid M; Reikvam DH
J Acquir Immune Defic Syndr; 2022 Jan; 89(1):77-86. PubMed ID: 34878437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
